Abdullah Husain

Hong Kong, HCW, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Correction: Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Journal: Molecular cancer

Published: September 04, 2026

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Journal: Molecular cancer

Published: January 28, 2026

Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression.

Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression.

Journal: Hepatology (Baltimore, Md.)

Published: September 13, 2025

Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumours.

Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumours.

Journal: International journal of surgery (London, England)

Published: June 26, 2025

Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumors.

Prospective analysis on the outcomes of histotripsy for primary and metastatic liver tumors.

Journal: International journal of surgery (London, England)

Published: June 26, 2025

Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma.

Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: June 10, 2025

Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response.

Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response.

Journal: Molecular cancer

Published: October 15, 2024

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.

Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.

Journal: Cell death & disease

Published: August 21, 2024

Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications.

Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications.

Journal: Hepatology (Baltimore, Md.)

Published: January 31, 2024

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC.

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC.

Journal: Hepatology (Baltimore, Md.)

Published: June 15, 2022

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.

Journal: Cellular and molecular gastroenterology and hepatology

Published: May 13, 2022

Reply to: 'EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma'.

Reply to: 'EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma'.

Journal: Journal of hepatology

Published: May 05, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026